Structurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor

Bioinorganic Chemistry and Applications

Volumn 2010, Issue , 2010, Pages

  Tsoupras, Alexandros B ^a   Roulia, Maria ^a   Ferentinos, Eleftherios ^a   Stamatopoulos, Ioannis ^a   Demopoulos, Constantinos A ^a   Kyritsis, Panayotis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955354251     PISSN: 15653633     EISSN: 1687479X     Source Type: Journal    
DOI: 10.1155/2010/731202     Document Type: Article

References (54)

1. Silvestru C., Drake J. E., Tetraorganodichalcogenoimidodiphosphorus acids and their main group metal derivatives Coordination Chemistry Reviews 2001 223 1 117 216
2. Haiduc I., Dichalcogenoimidodiphosphinato ligands Comprehensive Coordination Chemistry II: From Biology to Nanotechnology 2003 1 Amsterdam, The Netherlands Elsevier 323 347
3. Chivers T., Konu J., Ritch J. S., Copsey M. C., Eisler D. J., Tuononen H. M., New tellurium-containing ring systems Journal of Organometallic Chemistry 2007 692 13 2658 2668
4. Levesanos N., Robertson S. D., Maganas D., Raptopoulou C. P., Terzis A., Kyritsis P., Chivers T., Ni [ (EP i Pr 2) 2 N ] 2 complexes: stereoisomers (E=Se) and square-planar coordination (E=Te) Inorganic Chemistry 2008 47 8 2949 2951
5. Simn-Manso E., Valderrama M., Boys D., Synthesis and single-crystal characterization of the square planar complex [Ni{(SPPh2)2N-S,S′}2]2THF Inorganic Chemistry 2001 40 14 3647 3649
6. Rsler R., Silvestru C., Espinosa-Prez G., Haiduc I., Cea-Olivares R., Tetrahedral versus square-planar NiS4 core in solid-state bis(dithioimidodiphosphinato)nickel(II) chelates. Crystal and molecular structures of Ni[(SPR2)(SPPh2)N]2(R=Ph,Me) Inorganica Chimica Acta 1996 241 2 47 54
7. Maganas D., Grigoropoulos A., Staniland S. S., Tetrahedral and square-planar Ni[(SPR2)2N]2 complexes, R=PhPir revisited: experimental and theoretical analysis of interconversion pathways, structural preferences and spin delocalization Inorganic Chemistry 2010 49 11 5079 5093
8. Ly T. Q., Woollins J. D., Bidentate organophosphorus ligands formed via P-N bond formation: synthesis and coordination chemistry Coordination Chemistry Reviews 1998 176 1 451 481
9. Solomon E. I., Szilagyi R. K., DeBeer George S., Basumallick L., Electronic structures of metal sites in proteins and models: contributions to function in blue copper proteins Chemical Reviews 2004 104 2 419 458
10. Demopoulos C. A., Pinckard R. N., Hanahan D. J., Platelet-activating factor. Evidence for 1- O -alkyl-2-acetyl- sn -glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators) Journal of Biological Chemistry 1979 254 19 9355 9358
11. Zimmerman G. A., McIntyre T. M., Prescott S. M., Stafforini D. M., The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis Critical Care Medicine 2002 30 5 S294 S301
12. Stafforini D. M., McIntyre T. M., Zimmerman G. A., Prescott S. M., Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes Critical Reviews in Clinical Laboratory Sciences 2003 40 6 643 672
13. Montrucchio G., Alloatti G., Camussi G., Role of platelet-activating factor in cardiovascular pathophysiology Physiological Reviews 2000 80 4 1669 1699
14. Demopoulos C. A., Karantonis H. C., Antonopoulou S., Platelet activating factora molecular link between atherosclerosis theories European Journal of Lipid Science and Technology 2003 105 11 705 716
15. Lpez-Novoa J. M., Potential role of platelet activating factor in acute renal failure Kidney International 1999 55 5 1672 1682
16. McManus L. M., Pinckard R. N., PAF, a putative mediator of oral inflammation Critical Reviews in Oral Biology and Medicine 2000 11 2 240 258
17. Kasperska-Zajac A., Brzoza Z., Rogala B., Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy Recent Patents on Inflammation and Allergy Drug Discovery 2008 2 1 72 76
18. Nathan N., Denizot Y., Huc M. C., Claverie C., Laubie B., Benveniste J., Arnoux B., Elevated levels of paf-acether in blood of patients with type 1 diabetes mellitus Diabete Metabolisme 1992 18 1 59 62
19. Tsoupras A. B., Iatrou C., Frangia C., Demopoulos C. A., The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants Infectious DisordersDrug Targets 2009 9 4 390 399
20. Tsoupras A. B., Chini M., Tsogas N., Fragopoulou E., Nomikos T., Lioni A., Mangafas N., Demopoulos C. A., Antonopoulou S., Lazanas M. C., Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection? AIDS Research and Human Retroviruses 2008 24 8 1079 1086
21. Negro lvarez J. M., Miralles Lpez J. C., Ortiz Martnez J. L., Abelln Alemn A A., Rubio Del Barrio R., Platelet-activating factor antagonists Allergologia et Immunopathologia 1997 25 5 249 258
22. Desquand S., Effects of PAF antagonists in experimental modelspossible therapeutic implications Therapie 1993 48 6 585 597
23. Koltai M., Hosford D., Guinot P., Esanu A., Braquet P., Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications. I. Drugs 1991 42 1 9 29
24. Koltai M., Hosford D., Guinot P., Esanu A., Braquet P., PAF: a review of its effects, antagonists and possible future clinical implications. II. Drugs 1991 42 2 174 204
25. Zhang C. X., Lippard S. J., New metal complexes as potential therapeutics Current Opinion in Chemical Biology 2003 7 4 481 489
26. van Rijt S. H., Sadler P. J., Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs Drug Discovery Today 2009 14 1089 1197
27. Timerbaev R., Advances in developing tris(8-quinolinolato)gallium(III) as an anticancer drug: critical appraisal and prospects Metallomics 2009 1 193 198
28. Jakupec M. A., Keppler B. K., Gallium in cancer treatment Current Topics in Medicinal Chemistry 2004 4 15 1575 1583
29. Marzano C., Pellei M., Tisato F., Santini C., Copper complexes as anticancer agents Anti-Cancer Agents in Medicinal Chemistry 2009 9 2 185 211
30. Chohan Z. H., Metal-based antibacterial and antifungal sulfonamides: synthesis, characterization, and biological properties Transition Metal Chemistry 2009 34 2 153 161
31. Sakurai H., Katoh A., Yoshikawa Y., Chemistry and biochemistry of insulin-mimetic vanadium and zinc complexes. Trial for treatment of diabetes mellitus Bulletin of the Chemical Society of Japan 2006 79 11 1645 1664
32. Kamalesh Babu R. P., Krishnamurthy S. S., Nethaji M., Short-bite chiral diphosphazanes derived from (S)- -methyl benzyl amine and their Pd, Pt and Rh metal complexes Tetrahedron Asymmetry 1995 6 2 427 438
33. Silvestru A., Rotar A., Drake J. E., Synthesis, spectroscopic characterization, and structural studies of new Cu(I) and Cu(II) complexes containing organophosphorus ligands, and crystal structures of (Ph3P)2Cu[S2PMe2], (Ph3P)2Cu[(OPPh2)2N], Cu[(OPPh2)2N]2, and Cu[(OPPh2)(SPPh2)N]2 Canadian Journal of Chemistry 2001 79 983 991
34. Silvestru A., Ban D., Drake J. E., Zinc(II) tetraorganodichalcogenoimidodiphosphinates. Crystal and molecular structure of Zn[(OPPh2)2N]2 Revue Roumaine de Chimie 2002 47 10-11 1077 1084
35. Davison A., Switkes E. S., The stereochemistry of four-coordinate bis(imidodiphosphinato)metal(II) chelate complexes Inorganic Chemistry 1971 10 4 837 842
36. Garca-Montalvo V., Cea-Olivares R., Williams D. J., Espinosa-Prez G., Stereochemical consequences of the bismuth atom electron lone pair, a comparison between MX6E and MX6 systems. Crystal and molecular structures of tris[ N -(P, P -diphenylphosphinoyl)- P, P -diphenylphosphinimidato]bismuth(III),[ [Bi{(OPPh2)2N}3], -indium(III), [In{(OPPh2)2N}3]C6H6, and -gallium(III), [Ga{(OPPh2)2N}3]CH2Cl2 Inorganic Chemistry 1996 35 13 3948 3953
37. Vougioukalakis G. C., Stamatopoulos I., Petzetakis N., Raptopoulou C. P., Psycharis V., Terzis A., Kyritsis P., Pitsikalis M., Hadjichristidis N., Controlled vinyl-type polymerization of norbornene with a nickel(II) diphosphinoamine/methylaluminoxane catalytic system Journal of Polymer Science A 2009 47 20 5241 5250
38. Wang F. T., Najdzionek J., Leneker K. L., Wasserman H., Braitsch D. M., Facile synthesis of imidotetraphenyldiphosphinic acids Synthesis and Reactivity in Inorganic and Metal-Organic Chemistry 1978 8 119 125
39. Lazanas M., Demopoulos C. A., Tournis S., Koussissis S., Labrakis-Lazanas K., Tsarouhas X., PAF of biological fluids in disease: I.V. Levels in blood in allergic reactions induced by drugs Archives of Dermatological Research 1988 280 2 124 126
40. Tsoukatos D., Demopoulos C. A., Tselepis A. D., Moschidis M. C., Donos A., Evangelou A., Benveniste J., Inhibition of cardiolipins of platelet-activating factor-induced rabbit platelet activation Lipids 1993 28 12 1119 1124
41. Noth H., Crystal and molecular-structure of imido-tetraphenyl-dithio- phosphinic acid and imido-tetraphenyl-diphosphinic acid Zeitschrift fr Naturforschung B 1982 37 1491 1498
42. Philippopoulos A. I., Tsantila N., Demopoulos C. A., Raptopoulou C. P., Likodimos V., Falaras P., Synthesis, characterization and crystal structure of the cis-[RhL2Cl2]Cl complex with the bifunctional ligand (L) 2-(2′ -pyridyl)quinoxaline. Biological activity towards PAF (Platelet Activating Factor) induced platelet aggregation Polyhedron 2009 28 15 3310 3316
43. Heuer H. O., Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists Lipids 1991 26 12 1369 1373
44. Fletcher J. R., DiSimone A. G., Earnest M. A., Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia Annals of Surgery 1990 211 3 312 316
45. Izquierdo I., Merlos M., Garca-Rafanell J., Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis Drugs of Today 2003 39 6 451 468
46. Huo Y., Ekholm J., Hanahan D. J., A preferential inhibition by Zn2+ on platelet activating factor- and thrombin-induced serotonin secretion from washed rabbit platelets Archives of Biochemistry and Biophysics 1988 260 2 841 846
47. Afanas'ev I. B., Ostrakhovitch E. A., Mikhal'chik E. V., Ibragimova G. A., Korkina L. G., Enhancement of antioxidant and anti-inflammatory activities of bioflavonoid rutin by complexation with transition metals Biochemical Pharmacology 2001 61 6 677 684
48. Dillon C. T., Hambley T. W., Kennedy B. J., Lay P. A., Zhou Q., Davies N. M., Biffin J. R., Regtop H. L., Gastrointestinal toxicity, antiinflammatory activity, and superoxide dismutase activity of copper and zinc complexes of the antiinfiammatory drug indomethacin Chemical Research in Toxicology 2003 16 1 28 37
49. Kovala-Demertzi D., Hadjipavlou-Litina D., Staninska M., Primikiri A., Kotoglou C., Demertzis M. A., Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II) Journal of Enzyme Inhibition and Medicinal Chemistry 2009 24 3 742 752
50. Mohan G., Nagar R., Agarwal S. C., Mehta KM. A., Rao C. S., Syntheses and anti-inflammatory activity of diphenylamine-2, 2′ -dicarboxylic acid and its metal complexes Journal of Enzyme Inhibition and Medicinal Chemistry 2005 20 1 55 60
51. Pereira R. M. S., Andrades N. E. D., Paulino N., Sawaya A. C. H. F., Eberlin M. N., Marcucci M. C., Favero G. M., Novak E. M., Bydlowski S. P., Synthesis and characterization of a metal complex containing naringin and Cu, and its antioxidant, antimicrobial, antiinflammatory and tumor cell cytotoxicity Molecules 2007 12 7 1352 1366
52. Pontiki E., Hadjipavlou-Litina D., Chaviara A. T., Evaluation of anti-inflammatory and antioxidant activities of copper (II) Schiff mono-base and copper(II) Schiff base coordination compounds of dien with heterocyclic aldehydes and 2-amino-5-methyl-thiazole Journal of Enzyme Inhibition and Medicinal Chemistry 2008 23 6 1011 1017
53. Melnikova V. O., Balasubramanian K., Villares G. J., Dobroff A. S., Zigler M., Wang H., Petersson F., Price J. E., Schroit A., Prieto V. G., Hung M.-C., Bar-Eli M., Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis Journal of Biological Chemistry 2009 284 42 28845 28855
54. Melnikova V. O., Bar-Eli M., Inflammation and melanoma metastasis Pigment Cell and Melanoma Research 2009 22 3 257 267